PKL-200

N/A

Report date: 2025/08/04 14:45:13
NME

Base Information

Drug NamePKL-200
Drug Alias NamePKL200PKL-200
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell membrane modulators
TargetsUpdating
Therapy Area/IndicationsEnterobacter Cloacae InfectionAcinetobacter Baumannii InfectionsEnterococcus Infections +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIntron Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesIntron Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsEnterobacter Cloacae InfectionAcinetobacter Baumannii InfectionsEnterococcus Infections +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A